Skip to main content
. 2020 Aug 28;9(20):7488–7502. doi: 10.1002/cam4.3343

TABLE 1.

Clinical and pathological parameters of patients involved in the present research

Training set Test set P value
n 405 62
Gender (%) .775
Female 217 (53.6) 35 (56.5)
Male 188 (46.4) 27 (43.5)
Age (%) .271
<=65 199 (50.4) 26 (41.9)
>65 196 (49.6) 36 (58.1)
Smoking history (%) .889
Nonsmoker 57 (14.5) 8 (12.9)
Smoker 336 (85.5) 54 (87.1)
AJCC stage (%) .578
Stage I 222 (55.5) 33 (55.9)
Stage II 95 (23.8) 11 (18.6)
Stage III 64 (16.0) 10 (16.9)
Stage IV 19 (4.8) 5 (8.5)
T classification (%) .351
T1 142 (35.3) 15 (24.2)
T2 213 (53.0) 39 (62.9)
T3 31 (7.7) 6 (9.7)
T4 16 (4.0) 2 (3.2)
N classification (%) .003
N0 265 (66.9) 38 (61.3)
N1 73 (18.4) 14 (22.6)
N2 57 (14.4) 7 (11.3)
N3 1 (0.3) 3 (4.8)
M classification (%) .864
M0 260 (93.5) 57 (91.9)
M1 18 (6.5) 5 (8.1)
OS_event (%) .118
Alive 309 (76.3) 41 (66.1)
Dead 96 (23.7) 21 (33.9)
OS_time (median [min, max]) 1.78 [0.09, 19.86] 2.48 [0.10, 10.07] .031

Abbreviation: OS, overall survival.